SMUG1 and breast cancer: Immunohistochemical analysis of breast cancer tissue arrays revealed that low SMUG1 expression correlates with highly aggressive tumor phenotypes, for which it has been suggested as an independent prognostic biomarker in ER-positive breast cancer and a predictive marker of response to adjuvant chemotherapy [181].